No Data
No Data
Windtree Therapeutics Raises $2.5M in Private Placement
Windtree Therapeutics Secures Rights To Acquire 436-Unit Multifamily Property In Houston
10-K: FY2024 Annual Report
Windtree Therapeutics Reports FY24 EPS ($104.35) Vs. ($4,718.84) Last Year
Windtree Therapeutics FY24 Loss $1.8M >WINT
Press Release: Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates